Concepedia

Yusuke Yano

YY

6

Publications

84

Citations

6

H-Index

2021

Active since

Affiliations

Osaka University of Pharmaceutical Sciences(Current)

Jikei University School of Medicine

Fujita Health University

Tokyo Medical University

Yusuke Yano is an author at Osaka University of Pharmaceutical Sciences specializing in oncology, radiation oncology, and urology.

Top concepts

Publications per year

2021–2022

6

Publications

6

Risk Classification for Overall Survival by the Neutrophil–Lymphocyte Ratio and the Number of Metastatic Sites in Patients Treated with Pembrolizumab—A Multicenter Collaborative Study in Japan

Taizo Uchimoto, Kazumasa Komura, Wataru Fukuokaya et al. · Cancers · 2021 · 17 citations · Full text

Serum C-reactive Protein Level Predicts Overall Survival for Clear Cell and Non-Clear Cell Renal Cell Carcinoma Treated with Ipilimumab plus Nivolumab

Yusuke Yano, Takaya Ohno, Kazumasa Komura et al. · Cancers · 2022 · 17 citations · Full text

, , +19

Unplanned hemodialysis initiation and low geriatric nutritional risk index scores are associated with end-stage renal disease outcomes

Ryoichi Maenosono, Tatsuo Fukushima, Daisuke Kobayashi et al. · Scientific Reports · 2022 · 15 citations · Full text

Efficacy of pembrolizumab and comprehensive CD274/PD-L1 profiles in patients previously treated with chemoradiation therapy as radical treatment in bladder cancer

Kazuki Nishimura, Kyosuke Nishio, Kensuke Hirosuna et al. · Journal for ImmunoTherapy of Cancer · 2022 · 13 citations · Full text

Prognostic value of the fluctuation in the neutrophil–lymphocyte ratio at 6 weeks of pembrolizumab treatment is specific to the clinical response in metastatic urothelial carcinoma

Taizo Uchimoto, Ko Nakamura, Kazumasa Komura et al. · Urologic Oncology Seminars and Original Investigations · 2022 · 12 citations

, , +7

Rows per page

1–5 of 6